However, the insulin-reactive CD8 T cells are capable of being highly pathogenic 14 and the ability to antagonize such cells and prevent them from causing early islet damage is likely to add benefit in protection against diabetes. The gene discussed is CD8A; the disease is diabetes mellitus.